Omega-3 fatty acids and sudden cardiac death in schizophrenia: If not a friend, at least a great colleague

Schizophrenia Research

Volumn 94, Issue 1-3, 2007, Pages 375-376

  Scorza, Fulvio A ^a   Cysneiros, Roberta M ^a   Cavalheiro, Esper A ^a   Arida, Ricardo M ^a   de Albuquerque, Marly ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE DE MOGI DAS CRUZES   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; ICOSAPENTAENOIC ACID; NEUROLEPTIC AGENT; OMEGA 3 FATTY ACID;

CARDIOVASCULAR DISEASE; HUMAN; LETTER; LIFESTYLE; METABOLIC SYNDROME X; MORTALITY; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SCHIZOPHRENIA; SUDDEN DEATH;

DEATH, SUDDEN, CARDIAC; DRUG ADMINISTRATION SCHEDULE; FATTY ACIDS, OMEGA-3; HUMANS; SCHIZOPHRENIA; TRIGLYCERIDES;

EID: 34447092397     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.04.004     Document Type: Letter

References (22)

1. Auquier P., Lancon C., Rouillon F., Lader M., and Holmes C. Mortality in schizophrenia. Pharmacoepidemiol Drug. Saf. 15 (2006) 873-879
2. Bobes J., Arango C., Aranda P., Carmena R., Garcia-Garcia M., Rejas J., and on behalf of the CLAMORS Study Collaborative Group. Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study. Schizophr. Res. 90 (2007) 162-173
3. Freeman M.P., Hibbeln J.R., Wisner K.L., Davis J.M., Mischoulon D., Peet M., Keck P.E., Marangell L.B., Richardson A.J., Lake J., and Stoll A.L. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J. Clin. Psychiatry 67 (2006) 1954-1967
4. Glassman A.H. Schizophrenia, antipsychotic drugs, and cardiovascular disease. J. Clin. Psychiatry 66 (2005) 5-10
5. Harris W.S. n-3 fatty acids and serum lipoproteins: human studies. Am. J. Clin. Nutr. 65 (1997) 1645S-1654S
6. Harris W.S., and von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease?. Prev. Med. 39 (2004) 212-220
7. Ismail H.M. The role of omega-3 fatty acids in cardiac protection: an overview. Front. Biosci. 10 (2005) 1079-1088
8. Khan M.M., Evans D.R., Gunna V., Scheffer R.E., Parikh V.V., and Mahadik S.P. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxidesin schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics. Schizophr. Res. 58 (2002) 1-10
9. Mazza M., Pomponi M., Janiri L., Bria P., and Mazza S. Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 31 (2007) 12-26
10. National Institute of Mental Health. The numbers count: mental disorders in America; 2006. NIH Pub. No. 06-4584. http://www.nimh.nih.gov/publicat/numbers.cfm.
11. Peet M., Horrobin D.F., and E-E Multicentre Study Group. A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. J. Psychiatr. Res. 36 (2002) 7-18
12. Raitt M.H., Connor W.E., Morris C., Kron J., Halperin B., Chugh S.S., McClelland J., Cook J., MacMurdy K., Swenson R., Connor S.L., Gerhard G., Kraemer D.F., Oseran D., Marchant C., Calhoun D., Shnider R., and McAnulty J. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 293 (2005) 2884-2891
13. Ruschena D., Mullen P.E., Burgess P., Cordner S.M., Barry-Walsh J., Drummer O.H., Palmer S., Browne C., and Wallace C. Sudden death in psychiatric patients. Br. J. Psychiatry 172 (1998) 331-336
14. Scorza F.A., Mari J.J., and Bressan R.A. Sudden cardiac death in schizophrenia: should the psychiatrist pay more attention?. Rev. Bras. Psiquiatr. 28 (2006) 339
15. Scorza F.A., Cysneiros R.M., Arida R.M., de Albuquerque M., and Cavalheiro E.A. Omega-3 fatty acids and sudden unexpected death in epilepsy: what does the evidence tell us?. Prog. Neuropsychopharmacol. Biol. Psychiatry. 31 (2007) 972-973
16. Singh R.B., Pella D., Mechirova V., and Otsuka K. Can brain dysfunction be a predisposing factor for metabolic syndrome?. Biomed. Pharmacother. 58 (2004) S56-S68
17. Straus S.M., Bleumink G.S., Dieleman J.P., van der Lei J., Jong G.W., Kingma J.H., Sturkenboom M.C., and Stricker B.H. Antipsychotics and the risk of sudden cardiac death. Arch. Intern. Med. 164 (2004) 1293-1297
18. von Schacky C. Omega-3 fatty acids and cardiovascular disease. Curr. Opin. Clin. Nutr. Metab. Care 10 (2007) 129-135
19. Yao J.K., van Kammen D.P., and Welker J.A. Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition. Schizophr. Res. 13 (1994) 217-226
20. Yao J.K., van Kammen D.P., and Gurklis J. Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures. Schizophr. Res. 13 (1994) 227-232
21. Yuen A.W., and Sander J.W. Is omega-3 fatty acid deficiency a factor contributing to refractory seizures and SUDEP? A hypothesis. Seizure 13 (2004) 104-107
22. Zarate C.A., and Patel J. Sudden cardiac death and antipsychotic drugs: do we know enough?. Arch. Gen. Psychiatry 58 (2001) 1168-1171